American Century Companies Inc. Raises Holdings in Colgate-Palmolive Company $CL

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

American Century Companies Inc. boosted its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 12.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 915,313 shares of the company's stock after purchasing an additional 98,605 shares during the quarter. American Century Companies Inc. owned about 0.11% of Colgate-Palmolive worth $85,765,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Personal CFO Solutions LLC bought a new stake in Colgate-Palmolive during the 1st quarter valued at approximately $285,000. Vision Capital Management Inc. bought a new stake in Colgate-Palmolive during the 1st quarter valued at approximately $322,000. Autumn Glory Partners LLC raised its stake in Colgate-Palmolive by 67.4% during the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock valued at $851,000 after purchasing an additional 3,586 shares during the period. Financial Gravity Asset Management Inc. bought a new stake in Colgate-Palmolive during the 1st quarter valued at approximately $2,166,000. Finally, Penserra Capital Management LLC raised its stake in Colgate-Palmolive by 398.6% during the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock valued at $997,000 after purchasing an additional 8,515 shares during the period. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Trading Down 0.6%

Shares of Colgate-Palmolive stock traded down $0.5010 on Friday, reaching $85.7790. The company had a trading volume of 2,744,226 shares, compared to its average volume of 5,211,539. The firm's 50-day moving average price is $87.69 and its two-hundred day moving average price is $89.91. Colgate-Palmolive Company has a 1 year low of $82.40 and a 1 year high of $109.30. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The firm has a market cap of $69.33 billion, a price-to-earnings ratio of 24.10, a P/E/G ratio of 4.47 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.11 billion during the quarter, compared to analysts' expectations of $5.03 billion. During the same quarter in the previous year, the business earned $0.91 EPS. Colgate-Palmolive's revenue was up 1.0% compared to the same quarter last year. As a group, research analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a dividend of $0.52 per share. The ex-dividend date was Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.4%. Colgate-Palmolive's payout ratio is presently 58.43%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on CL shares. JPMorgan Chase & Co. decreased their target price on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Citigroup reduced their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research note on Monday, August 4th. Barclays lifted their price objective on Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 15th. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Finally, Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research note on Monday, August 4th. Seven analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $98.92.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.